This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
August 13, 2019
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
August 12, 2019
Targovax ASA: Announcement of second quarter and first half results 2019
August 05, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
August 05, 2019
Altimmune to Announce Second Quarter 2019 Financial Results on August 14
August 01, 2019
Q2 2019 General Market Overview
July 31, 2019
Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update
July 31, 2019
Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC
July 29, 2019
Rainier Therapeutics Announces Vofatamab FIERCE-22 Data Accepted for Presentation at ESMO 2019 Annual Congress
July 25, 2019
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report
July 25, 2019
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2019 Interim report